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Edited by Maurice MontalAbstract Bacillus thuringiensis subs israelensis produces Cry
toxins active against mosquitoes. Receptor binding is a key
determinant for speciﬁcity of Cry toxins composed of three do-
mains. We found that exposed loop a-8 of Cry11Aa toxin, lo-
cated in domain II, is an important epitope involved in receptor
interaction. Synthetic peptides corresponding to exposed regions
in domain II (loop a-8, b-4 and loop 3) competed binding of
Cry11Aa to membrane vesicles from Aedes aegypti midgut
microvilli. The role of loop a-8 of Cry11A in receptor interaction
was demonstrated by phage display and site-directed mutagene-
sis. We isolated a peptide-displaying phage (P5.tox), that recog-
nizes loop a-8 in Cry11Aa, interferes interaction with the midgut
receptor and attenuates toxicity in bioassay. Loop a-8 mutants
aﬀected in toxicity and receptor binding were characterized.
 2005 Federation of European Biochemical Societies. Published
by Elsevier B.V. All rights reserved.
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Epitope mapping1. Introduction
Bacillus thuringiensis subsp. israelensis (Bti) is highly toxic to
diﬀerent mosquito species like Aedes spp., Culex spp., and
Anopheles spp., human diseases vectors [1]. Bti formulations
are used worldwide for mosquito control. This bacterium pro-
duces crystal inclusions composed of Cry4Aa, Cry4Ba,
Cry10Aa, Cry11Aa, Cyt1Aa and Cyt2Ba toxins [2]. The crys-
tals ingested by susceptible larvae dissolve in the alkaline gut
environment, releasing soluble proteins. The inactive Cry pro-
toxins are cleaved at speciﬁc sites by midgut proteases yielding
active protease resistant fragments [3]. In the case of the
70 kDa Cry11Aa protoxin, proteolytic activation using gut ex-
tract removes 28 residues from N-terminal and cleaves intra-
molecularly resulting in 34 and 32 kDa fragments [4].
However, the in vitro activation with trypsin produced two
fragments of 36 and 32 kDa [4–6]. In both cases, the two frag-Abbreviations: BBMV, brush border membrane vesicles; PFU, plaque-
forming units; ELISA, enzyme-linked immunosorbent assay
*Corresponding author. Fax: +52 777 3172388.
E-mail address: mario@ibt.unam.mx (M. Sobero´n).
0014-5793/$30.00  2005 Federation of European Biochemical Societies. Pu
doi:10.1016/j.febslet.2005.05.032ments remains associated and retain toxicity [4–7]. The active
Cry toxins bind to speciﬁc membrane receptors on the apical
brush border of midgut columnar cells leading to membrane
insertion and pore formation [3].
The crystal structures of Cry1Aa (lepidopteran speciﬁc),
Cry3A (coleopteran speciﬁc) and Cry2Aa (dipteran–lepidop-
teran speciﬁc) have been solved [8–10]. Seven a-helices form
the-N-terminal domain I, the pore-forming domain. Domain
II consists of three anti parallel b-sheets with exposed loop re-
gions and domain III is a b-sandwich [8–10]. Domains II-III
are important in receptor recognition, in particular, loop re-
gions of domain II are involved in receptor binding [11].
In the case of lepidopteran-speciﬁc Cry1A toxins, several
binding epitopes in the cadherin receptor that recognized three
loops of domain II were identiﬁed [12–14]. In the case of dip-
teran speciﬁc toxins, loop 1 of Cry1Ca toxin (with dipteran
and lepidopteran activity) is important for toxicity against
mosquitoes but not against lepidopteran [15]. Furthermore,
loop 2 appears to play an important role in Ae. aegypti activity
[16]. For Cry4Ba toxin, amino acid substitutions in loops 1, 2
and 3 aﬀected toxicity to diﬀerent mosquitoes [17]. Collec-
tively, these results show that the loop regions of domain II
are also important determinants for receptor interaction for
mosquitocidal Cry proteins.
Cry11Aa is the most active toxin found in the Bti crystal
against Ae. aegypti and the regions involved in the interaction
with its receptor remain uncharacterized. Previous work in our
laboratory demonstrated that phage-display is a powerful
methodology to identify receptor-binding epitopes of Cry1A
toxins [18]. This technology may provide means for receptor
identiﬁcation, since it is possible to expect that peptide-phages
that bind the toxin and mimic the receptor may share some pri-
mary sequence similarity with the receptor [19]. The mapping
of binding epitopes of Cry11Aa is a challenging problem since,
in contrast to Cry1A lepidopteran-toxins, no 3-D structure of
Cry11Aa is available, no mutagenesis studies of receptor bind-
ing domains have been performed and the identity of its recep-
tor(s) remains unknown. By using synthetic peptides that
correspond to exposed regions in domain II of Cry11A, we
identiﬁed speciﬁc regions in this toxin involved in the interac-
tion with midgut microvilli membranes from Ae. aegypti. We
also report here the isolation of peptide-displaying phages that
bind to Cry11Aa. Some of these phages interfere with the
Cry11Aa-receptor interaction in Ae. aegypti brush border
membrane vesicles (BBMV). Phage P5.tox recognized domainblished by Elsevier B.V. All rights reserved.
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the toxin with its receptor. Finally, mutants in loop a-8 that
impaired toxicity and receptor interaction were isolated and
characterized. Our results show that the exposed loop a-8
of Cry11Aa domain II is an important epitope for receptor
interaction.2. Materials and methods
2.1. Puriﬁcation and activation of Cry11Aa toxin
Cry11Aa was produced in Bt CG6 harboring pCG6 plasmid that en-
codes the cry11Aa gene [20]. Bt was grown in nutrient broth sporula-
tion medium [21] supplemented with erythromycin (25 lg/ml) at
200 rpm and 30 C until complete sporulation. Spores/crystals were
washed three-times with PBS (150 mM NaCl, 2.8 mM NaH2PO4,
4 mM Na2HPO4 Æ 7H2O, and pH 7.2) containing 1 mM EDTA,
0.1 mM PMSF, 1 lg/ml pepstatin and 5 lg/ml leupectin. Crystals were
isolated by sucrose gradients [22] and solubilized 1 h at 4 C with 0.1 M
NaOH. The pH of solution containing soluble protoxin was decreased
to pH 9 by addition of same volume of 1 M Tris–HCl, pH 8.0 and then
protoxin was activated with trypsin (1:50 w/w) for 2 h at 25 C.
2.2. Preparation of BBMV
Ae. aegypti eggs were supplied by Dr. J. Ibarra (CINVESTAV,
Irapuato). Mosquito larvae were feed with artiﬁcial diet. BBMV were
prepared from dissected midguts of 4th-instar larvae as reported [23]
and stored at 70 C until used.
2.3. Qualitative binding assays with isolated BBMV
Cry11A toxin was biotinylated using biotinyl-N-hydroxysuccinimide
ester (Amersham Pharmacia Biotech). Binding of 10 nM labelled toxin
to 10 lg Ae. aegypti BBMV protein was done in 100 ll binding buﬀer
(1· PBS, 0.1% BSA, 0.1% Tween 20, and pH 7.6). After 1 h at 25 C,
unbound toxin was removed by centrifugation (10 min at 14000 · g).
The pellet containing the BBMV with bound toxin was washed twice
with 100 ll same buﬀer and ﬁnally suspended in 1· PBS, pH 7.6. An
equal volume of 2· sample loading buﬀer (0.125 M Tris–HCl, pH
6.8, 4% SDS, 20% glycerol, 10% 2-mercaptoethanol, and 0.01% bro-
mophenol blue) was added, samples were boiled 3 min, loaded in
SDS–polyacrilamide gel (10%) and electrotransferred to nitrocellulose
membranes. The biotinylated protein was visualized by incubation
with streptavidin-peroxidase conjugated (1:6000 dilution) for 1 h,
followed by incubation with luminol (ECL, Amersham Pharmacia
Biotech). For competition assays the biotinylated toxin was pre-
incubated with phages or the BBMV were incubated with synthetic
peptides 1 h at room temperature before incubated with BBMV or
Cry11A, respectively.
2.4. Phage display library
The commercial phage-peptides library used in this work (New Eng-
land BioLabs Inc. Ph.D.-12 Phage Display Peptide Library Kit) has a
complexity of 2.7 · 109 transformants, based on a combinatorial li-
brary of random 12-mers fused to the M13 phage minor coat protein
(pIII).Table 1
Synthetic peptide sequences
Name Sequence
Loop a8 GVSIPVNYNEWY
Loop 1 DIPARENIRGVH
b4 GNGRTNNFNFADNN
b5 TFYQNPNNEPIAPR
b6 APAPADLFFKNADI
Loop2 FTQWFQSTLYG
Loop3 LTYNRIEYDSPTTEN
P5.tox FHWRWPPSLQIM2.5. Selection and sequencing of peptide-displaying phage clones
Cry11Aa-binding phages were selected by four rounds of panning in
immunotubes (Nalge Nunc, Denmark) coated with 100 lg/ml of acti-
vated Cry11A toxin 12 h at 4 C in 0.1 M NaHCO3, pH 9.6. The tubes
were washed four-times with washing buﬀer (PBS, 0.1% Tween 20 v/v)
and blocked 2 h at room temperature in 0.1 M NaHCO3 pH 9.6, 5 mg/
ml BSA, 0.02% NaN3. After blocking, 1 · 1011 plaque-forming units
(PFU) of the phage display library were added in washing buﬀer for
1 h at room temperature. Unbound phages were washed oﬀ six-times
in washing buﬀer and bound phages were separated from Cry11Aa
by acidic treatment using elution buﬀer (0.2 M Glycine–HCl, pH 2.2,
and 1 mg/ml BSA) 10 min at room temperature. Phages were neutral-
ized with 1 M Tris–HCl, pH 9.1 and used to perform subsequent
rounds of selection. To increase the speciﬁcity of the selected phages,
increasing concentrations of Tween 20 (0.1–0.4%), were employed in
each panning-round.
The DNA from independent phages, selected after 3rd and 4th-
rounds was puriﬁed and sequenced using primer 5 0-GCCCTCA-
TAGTTAGCGTAACG-30 provided in the Phage Display Peptide
Library-Kit.
2.6. Phage titter determinations
The phage enrichment was analyzed by enzyme-linked immunosor-
bent assay (ELISA) using the phage-pools obtained after each round
of selection. Immunosorbent polystyrene 96-well plate (Costar, NY,
USA) incubated 12 h with 5 lg/ml of Cry11Aa toxin in 0.1 M NaH-
CO3 pH 9.6 at 4 C were washed three times with washing buﬀer
and incubated with blocking buﬀer (PBS, 2% milk, and 0.1% Tween
20 v/v) 2 h at 37 C. Blocked plates were incubated with pools of
phages (1010 PFU) 1 h at 37 C in blocking buﬀer. Plates were washed
six-times in washing buﬀer and incubated with anti-M13 antibody
(1:2000) in blocking solution 1 h at room temperature. The plates were
then washed three-times with washing buﬀer and incubated with anti-
mouse-HRP antibody (1:2000). Finally, plates were incubated with
2 mM o-phenylene-diamine, 0.7% H2O2 in 0.1 M Na2HPO4, pH 5.
The enzymatic reaction was stopped with 6 N HCl and the absorbance
read at 490 nm with a LKB Ultraspec II (Pharmacia, Uppsala,
Sweden).
For competition assays, increasing concentration of synthetic pep-
tides (Table 1, from 0.1 to 100 lg/ml), were added during the incuba-
tion with the selected phages.
2.7. Insect bioassays
Fifteen early fourth-instar Ae. aegypti larvae reared at 28 C, 87%
humidity and 12:12 light: dark were placed in 100 ml de-chlorinated
water. The eﬀect of Cry11Aa (150–600 ng/ml) on mortality was ana-
lyzed after 24 h. For bioassays performed in the presence of competi-
tors (selected phages), the phages were mixed with the toxin during 1 h
and then the mixtures were added to the cups in a ﬁnal concentration
of 1011 phages/100 ml H2O.2.8. Site directed mutagenesis of Cry11Aa toxin
Mutagenesis of pGC6 plasmid was performed using Quik-
Change XL-kit (Stratagene, La Jolla CA). Appropriate oligonucle-
otides were synthesized for each mutant construction. Mutants
were sequenced and transformed into acrystalliferous Bt strain
407 [24].Description
Amino acid sequence of residues 257–268 Cry11Aa
Amino acid sequence of residues 298–309 Cry11Aa
Amino acid sequence of residues 323–336 Cry11Aa
Amino acid sequence of residues 347–360 Cry11Aa
Amino acid sequence of residues 369–382 Cry11Aa
Amino acid sequence of residues 386–396 Cry11Aa
Amino acid sequence of residues 447–461 Cry11Aa
Sequence of peptide displayed in P5.tox
3510 L.E. Ferna´ndez et al. / FEBS Letters 579 (2005) 3508–35142.9. Construction of a Cry11Aa structural model
The secondary structure was predicted using Psipred 2.3 [25], using
default conditions with a proﬁle derived from a psi-blast 2.2 [26],
searched against nrNCBI protein database (ftp://ftp.ncbi.nlm.nih.-
gov/blast/db/) ﬁltered for coiled-coils and poorly informative regions.
The Cry11Aa secondary-structure prediction was threaded against
the whole backbone database with Threader 3.4 [27]. Top signiﬁcant
hits corresponded to Cry protein structures. Threadings were run
against a subset of database that included 20 top-hits in a 50 random-
izations shuﬄing test. The top hit corresponded to the Cry2Aa (PDB
1i5p). We used the alignment produced by Threader to build a model
with Modeller 6v2.31. We added solvent with VMD 1.8.1 [28], and a
Molecular dynamics (MD) run using NAMD 2.5 [29], for 500000
steps. The energy levels were analyzed to ensure that the run was taken
to equilibrium and averaged the last 50 models obtained in MD simu-Fig. 1. Three Cry11Aa domain II regions are involved in the interaction be
domain II sequences from Cry11Aa and Cry2Aa toxins. The secondary struct
residues. (B) 3D-structural model of Cry11Aa. The model was obtained b
Cry11Aa important in receptor-binding are indicated, loop a8 (in orange), lo
(P261, V262 and E266) are represented in dark green.lation to obtain a working structural model. Prediction of exposed re-
gions was performed using the Predict Protein server with the solvent
accessibility module PHDacc [30,31].3. Results
3.1. Mapping the Cry11Aa epitopes involved in toxin–receptor
interaction
The identiﬁcation of the regions in domain II of Cry11Aa
possible involved in receptor interaction, was based on the
structure alignment with Cry2Aa, which gave the highest
score. Fig. 1A shows the alignment of Cry11Aa and Cry2Aatween Cry11Aa and Ae. aegypti BBMV. (A) Amino acid alignment of
ures are indicated. Underlined residues correspond to predicted exposed
ased on the Cry2A-structure. The predicted regions on domain II of
op3 (in red) and b-4 (in yellow). Also, mutated amino acids on loop a8
Fig. 2. Heterologous binding competition assays of Cry11Aa to BBMV in the presence of diﬀerent synthetic peptides. Biotinylated Cry11A toxin,
10 nM, was incubated with 10 lg BBMV, in the presence or absence of several-fold molar excess of the diﬀerent synthetic peptides. After washing the
unbound toxin the samples were loaded in 10% SDS–PAGE gels and electro-blotted on Hybond nitrocellulose membranes. The biotinylated
Cry11Aa toxin was visualized with streptavidin-peroxidase conjugate and incubation with SuperSignal chemioluminescence substrate.
Fig. 3. Selection of peptide-displaying phages that bind Cry11Aa toxin. (A) Equal numbers of phages selected after each round of panning were used
to determine the enrichment of phages that bind Cry11A toxin by ELISA. The output of each panning round is shown. In each round of selection the
concentration of Tween 20 was increased as indicated to improve speciﬁcity. Round 0 is 1.5 · 1010 plaque-forming units/ml phages of original library.
(B) Relative aﬃnities for Cry11Aa toxin, determined by ELISA, for individual peptide-displaying phages selected from the fourth round of panning
against Cry11A toxin.
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Cry11Aa. However, a poor alignment of the two sequences
was observed in the region between b-4 and b-6. Therefore, a
prediction of exposed residues in this particular region was
performed, indicating the presence of three putative-exposed
amino acid regions (Fig. 1B). One of these regions corresponds
to the previously described site of protease cleavage, conﬁrm-
ing that it is exposed [4–7]. Synthetic-peptides corresponding
to putative loop-regions (loop a-8, loop 1, loop 2 and loop
3, respectively) and to putative exposed-regions between b-4
and b-6 (b-4, b-5 and b-6, Fig. 1A, Table 1) were synthesized
and used as competitors in binding of biotynilated-Cry11Aa
to BBMV. Fig. 2 shows that three peptides corresponding to
loop a-8, loop 3 and b-4 competed the binding of Cry11Aa
to Ae. aegypti BBMV. Fig. 1B shows a space-ﬁlling represen-
tation of predicted loop a-8, b-4 and loop 3 involved in recep-
tor interaction.3.2. Isolation of Cry11Aa-binding peptides from a random
peptide-displaying phage library
To study the Cry11Aa-receptor interaction, a phage-display
library was panned against immobilized Cry11Aa toxin for
four rounds of selection. Enrichment of phages that bind
Cry11Aa toxin was demonstrated by ELISA (Fig. 3A).
Ten random selected phages from the fourth round of selection
were sequenced and six diﬀerent sequences were identiﬁed.
One sequence was represented in four phages (P1.tox:
WHWSLWRPPYTL), one in two phages (P5.tox:
FHWRWPPSLQIM) while the other phages encoded unique
peptides (P2.tox: FHRTPWLQFSLP, P3.tox: LHRPHL-
YHVWQR, P4.tox: WHWSWIQNAAPN, P6.tox: WHWSY-
ASQLLQI). The amino acid sequence displayed in phages
P1.tox, P4.tox and P6.tox shared the motif WHWS although
they showed diﬀerent binding properties (see below). P1.tox
binds Cry11Aa in a dose-dependent manner and showed the
Fig. 4. Identiﬁcation of peptide-displaying phages selected against
Cry11A toxin that inhibit Cy11Aa binding to BBMV. (A) Qualitative
binding assay of biotinylated Cry11Aa toxin to BBMV in the presence
of diﬀerent individual phages (1 · 1011 PFU) selected from panning
against Cry11Aa toxin. The results are representative of three
independent experiments. (B) Phage P5.tox binds Cry11Aa toxin
through loop a-8. ELISA assay of P5.tox phage binding (1010 PFU) to
Cry11Aa toxin and competition in the presence of diﬀerent concen-
trations of synthetic peptides. Five lg/ml of Cry11A toxin were ﬁxed
on the 96-well plates. The results are representative of three indepen-
dent experiments.
Table 2
Toxicity of Cry11Aa toxin to Ae. aegypti fourth instar larvae in the
presence or absence of peptide-phage competitors
Treatment Mortalitya%
Cry11Aab 72 ± 2.9
Cry11Aa/ P5.tox 38 ± 4.5
Cry11Aa/P2.tox 71 ± 1
H2O 0
a45 larvae per treatment ± standard error of three experiments.
b300 ng/ml of Cry11A toxin plus 1011 colony forming units of peptide-
displaying phages/cup as competitors.
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ELISA, while the P2.tox phage revealed the lowest apparent
binding-aﬃnity to the toxin (Fig. 3B). Competition binding
assays of Cry11Aa toxin to Ae. aegypti BBMV showed that
P1.tox, P3.tox, P5.tox and P6.tox phages competed binding
(Fig. 4A).
3.3. Analysis of epitopes in Cry11Aa toxin recognized by the
peptide-displaying phages
We analyzed if the phages selected against Cry11Aa that
competed the binding of Cry11Aa to Ae. aegypti BBMV, also
recognized the epitopes in domain II identiﬁed as putative tox-
in-receptor interacting regions (loop a-8, loop 3 and b-4). We
competed the binding of P1.tox, P3.tox, P5.tox or P6.tox
phages to Cry11Aa with synthetic loop a-8, loop3 and b-4 pep-
tides. Fig. 4B shows that the binding of P5.tox phage to
Cry11Aa was competed by loop a-8 peptide and by a synthetic
peptide corresponding to P5.tox displayed-peptide indicating
that this phage recognized Cry11Aa by interacting with loop
a-8 region. In contrast, b-4 and loop3 peptides did not com-
pete the binding of P5.tox phage to Cry11Aa. The binding
of the other phages to Cry11Aa was not competed by any loop
peptide (data not shown).
To determine if loop a-8 is involved in Cry11Aa toxicity,
Ae. aegypti larvae were fed with Cry11Aa and of P5.tox phage.
Table 2 shows that the toxicity of Cry11Aa was reduced 50%
when the toxin was incubated with P5.tox in contrast to
P2.tox. None of the selected phages was toxic against Ae. ae-
gypti larvae when assayed alone (data not shown).
3.4. Involvement of domain II loop a-8 residues in Cry11Aa
toxicity
Mutagenesis of loop a-8 (259SIPVNYNEW267) was per-
formed. We decide to replace some residues by alanine sincethis residue is not expected to have major structural eﬀects
on the protein. In addition, preliminary data showed that
V262A was aﬀected in toxicity so this hydrophobic residue
was changed with a polar residue as glutamic acid. The stabil-
ity of mutated proteins was determined after solubilization and
trypsin activation. All mutants, except V262E, were activated
to 36 and 32 kDa proteins as the wild type toxin, suggesting
that these mutations did not cause major structural distur-
bance (Fig. 5A). Mutant V262E was not proteolitically pro-
cessed since only a 68-kDa protein was observed. Mutants
V262E and E266A were severally aﬀected in their toxicity
against Ae. aegypti larvae (Table 3). A moderate eﬀect in tox-
icity was observed for mutants P261A and V262A while the
remainder mutants were not aﬀected (Table 3). A qualitative
binding assay of biotinylated Cry11Aa mutant-proteins to
Ae. aegypti-BBMV was performed. Fig. 5B shows that
E266A binds poorly to Ae. aegypti-BBMV in contrast with
Cry11A toxin. Mutant V262A also showed less binding to
BBMV (Fig. 5B). In addition heterologous binding competi-
tion of Cry11Aa toxin to BBMV with the mutated proteins
showed that E266A, V262A and P261A were less eﬃcient to
compete with the binding of biotinylated Cry11Aa suggesting
that these mutants bind BBMV with lower binding aﬃnity
than Cry11Aa toxin (Fig. 5C).4. Discussion
Receptor recognition by Cry toxins is a limiting step in their
mode of action. Mapping the interacting epitopes provides
information about the intoxication-process but also may oﬀer
tools for toxin improvement and for developing strategies to
cope with potential problems of insect resistance. In this work
we suggest that Cry11Aa–receptor interaction involves at least
three exposed regions of domain II (loop a-8, b-4 and loop3).
It was previously suggested that domain II region (V256–
R360) was important for toxicity but not for association of
Cry11Aa 32 and 36 kDa fragments [7] suggesting that V256–
R360 region was involved on receptor interaction [7]. Compe-
tition binding assays of Cry11Aa to Ae. aegypti BBMV
showed that synthetic peptides corresponding to loop a-8,
and b-4, that are included in V256–R360 region in the
36 kDa fragment, competed with binding of the toxin to
BBMV. In addition, loop3 (L447-T458), located in the 32
kDa C-terminal fragment, also competed the binding of
Cry11Aa to Ae. aegypti BBMV (Fig. 2), suggesting that loop3
may be also involved in receptor-interaction. Loop a-8 mu-
tants (P261A, V262E, V262A and E266A) were aﬀected in
BBMV binding and toxicity conﬁrming the role of loop a-8
on receptor-interaction. However, V262E showed structural
Fig. 5. Involvement of domain II loop a-8 residues in Cry11Aa binding to Ae. aegypti BBMV. (A) 10% SDS–PAGE electrophoretic pattern of
protoxins and trypsin activated loop a-8 mutants. (B) Binding of biotinylated mutants to Ae. aegypti four instar larvae BBMV vesicles. (C)
Heterologous binding competition of biotinylated 15 Cry11Aa toxin to BBMV with the unlabelled mutant proteins or Cry11Aa toxin (1–500-fold
excess of competitor).
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not correctly processed by trypsin. Mutagenesis of b-4 and
loop 3 residues will reveal their role on receptor interaction.
For Cry1A lepidopteran-speciﬁc toxins three loops of domain
II are involved in receptor-interaction [11–14]. Therefore, it is
possible that also several regions of Cry11Aa are involved in
receptor-recognition.
In this work, we isolated a peptide-displaying phage (P5.tox)
that binds Cry11Aa toxin in the loop a-8 and this phage also
competed with toxin binding to BBMV and lowered Cry11Aa
toxicity to Ae. aegypti larvae. The protein databases were
searched with the amino acid sequence of P5.tox peptide asTable 3
Biological activity of Cry11Aa mutant proteins to A. aegypti larvae
Toxins LC50
a(ng/ml)
Cry11Aa 78(40–112)
S259A 85(57–113)
P261A 267 (210–370)
V262A 421(327–585)
V262E >30000
N263A 79(53–104)
E266A 1668(1022–3622)
Bioassays were performed with 15 early fourth-instar Ae. aegypti lar-
vae in 100 ml H2O per dose. Three independent experiments of ten
diﬀerent doses each were done.
a95% conﬁdence limits are given in parentheses.an attempt to identify putative receptor molecules since
P5.tox was shown to mimic the receptor in the interaction with
loop a-8. A hit was obtained with the Anopheles gambiae gen-
ome (ENSANGP00000018184). This putative glycosylated
protein has a predicted molecular weight of 101.5 kDa and is
predicted to be a membrane bound protein with the N-termi-
nal end exposed to the exterior of the cell. However, we cannot
rule out the possibility of multiple receptor molecules could be
involved on Cry11Aa interaction with the midgut epithelia as
is the case of Cry1A toxins that at least two functional receptor
molecules bind toxin sequentially leading to toxin membrane
insertion [32]. The possible role of this putative 100-kDa pro-
tein as receptor of Cry11Aa could be analyzed by RNA inter-
ference to determine if silenced larvae become resistant to the
Cry11Aa toxin (work in progress).
We isolated other phages that bind Cry11Aa toxin and inhi-
bit the interaction of the toxin to Ae. aegypti BBMV (phages
P1.tox, P3.tox and P6.tox), but the binding of these phages
to Cry11Aa toxin was not competed by the Cry11A synthetic
peptides. These data suggest that these phages recognized
other toxin epitopes that may be involved in receptor-interac-
tion. One alternative would be that some of them recognize do-
main III epitopes, which in Cry1A are also important for
receptor-interaction [3]. Mapping the binding epitopes recog-
nized by phages P1.tox, P3.tox and P6.tox could reveal addi-
tional toxin regions involved in receptor-interaction.
However, it is possible that binding of the phage near an
3514 L.E. Ferna´ndez et al. / FEBS Letters 579 (2005) 3508–3514exposed domain II loop region could interfere with receptor
interaction by steric hindrance due to the size of the phage par-
ticle. This remains to be determined by using synthetic peptides
as competitors in the toxin-receptor interaction.
Overall, the data presented in this work indicates that loop
a-8 region from Cry11Aa constitute an important epitope in
the interaction of this toxin with its receptor and in Cry11Aa
toxicity. The mutagenesis of speciﬁc loop a-8 residues con-
ﬁrmed this conclusion.
Acknowledgments: To Lizbeth Cabrera and Oswaldo Lopez for techni-
cal assistance. This research was supported in part by DGAPA/
UNAM IN207503-3, IN206503-3 and IX217404, CONACyT 36505-
N and USDA 2002-35302-12539. L.E.F. to DGEP for PhD fellowship.References
[1] Margalith, Y. and Ben-Dov, E. (2000) in: Insect Pest Manage-
ment: Techniques for Environmental Protection (Rechcigl, J.E.
and Rechcigl, N.A., Eds.), p. 243, CRC Press, Boca Raton.
[2] Porter, A.G., Davidson, E.W. and Liu, J.W. (1993) Mosquitoci-
dal toxins of bacilli and their genetic manipulation for eﬀective
biological control of mosquitoes. Microbiol. Rev. 57, 838–861.
[3] de Maagd, R.A., Bravo, A. and Crickmore, N. (2001) How
Bacillus thuringiensis has evolved speciﬁc toxins to colonize the
insect world. Trends Genet. 17, 193–199.
[4] Yamahiwa, M., Ogawa, R., Yasuda, K., Natsuyama, H., Sen, K.
and Sakai, H. (2002) Active form of dipteran-speciﬁc insecticidal
protein Cry11A produced by Bacillus thuringiensis subsp. israel-
ensis. Biosci. Biotechnol. Biochem. 66, 516–522.
[5] Revina, L.P., Kostina, L.I., Ganushkina, L.A., Zalunin, I.A. and
Chestukina, G.G. (2004) Reconstruction of Bacillus thuringiensis
ssp. israelensis Cry11A endotoxin from fragments corresponding
to its N- and C-moieties restores its original biological activity.
Biochemistry (Moscow) 69, 181–187.
[6] Dai, S.M. and Gill, S.S. (1993) In vitro and in vivo proteolysis of
the Bacillus thuringiensis subsp. israelensis CryIVD protein by
Culex quinquefasciatus larval midgut proteases. Ins. Biochem.
Mol. Biol. 23, 273–283.
[7] Yamagiwa, M., Sakagawa, K. and Sakai, H. (2004) Functional
analysis of two processed fragments of Bacillus thuringiensis
Cry11A toxin. Biosci. Biotechnol. Biochem. 68, 523–528.
[8] Grochulski, P., Masson, L., Borisova, S., Pusztai-Carey, M.,
Schwartz, J.L., Brousseau, R. and Cygler, M. (1995) Bacillus
thuringiensis CryIA(a) insecticidal toxin: crystal structure and
channel formation. J. Mol. Biol. 254, 447–464.
[9] Li, J., Carroll, J. and Ellar, D.J. (1991) Crystal structure of
insecticidal delta-endotoxin from Bacillus thuringiensis at 2.5. A˚
resolution. Nature 353, 815–821.
[10] Morse, R.J., Yamamoto, T. and Stroud, R.M. (2001) Structure of
Cry2Aa suggests an unexpected receptor binding epitope. Struc-
ture 9, 409–417.
[11] Schnepf, E., Crickmore, N., Van Rie, J., Lereclus, D., Baum, J.,
Feitelson, J., Zeigler, D.R. and Dean, D.H. (1998) Bacillus
thuringiensis and its pesticidal crystal proteins. Microbiol. Mol.
Biol. Rev. 62, 775–806.
[12] Gomez, I., Miranda-Rios, J., Rudin˜o-Pin˜era, E., Oltean, D.I.,
Gill, S.S., Bravo, A. and Sobero´n, M. (2002) Hydropathic
complementarity determines interaction of epitope (869)HIT-
DTNNK(876) in Manduca sexta Bt-R(1) receptor with loop 2 of
domain II of Bacillus thuringiensis Cry1A toxins. J. Biol. Chem.
277, 30137–30143.
[13] Gomez, I., Dean, D.H., Bravo, A. and Soberon, M. (2003)
Molecular basis for Bacillus thuringiensis Cry1Ab toxin speciﬁcity:
two structural determinants in the Manduca sexta Bt-R1 receptorinteract with loops alpha-8 and 2 in domain II of Cy1Ab toxin.
Biochemistry 42, 10482–10489.
[14] Xie, R., Zhuang, M., Ross, L.S., Go´mez, I., Oltean, D.I.,
Bravo, A., Sobero´n, M. and Gill, S.S. (2005) Single amino acid
mutations in the cadherin receptor from Heliothis virescens
aﬀect its toxin binding ability to Cry1A toxins. J. Biol. Chem.
280, 8416–8425.
[15] Smith, G.P. and Ellar, D.J. (1994) Mutagenesis of two surface-
exposed loops of the Bacillus thuringiensis CryIC delta-endotoxin
aﬀects insecticidal speciﬁcity. Biochem. J. 302, 611–616.
[16] Abdul-Rauf, M. and Ellar, D.J. (1999) Mutations of loop 2 and
loop 3 residues in domain II of Bacillus thuringiensis Cry1C delta-
endotoxin aﬀect insecticidal speciﬁcity and initial binding to
Spodoptera littoralis and Aedes aegypti midgut membranes. Curr.
Microbiol. 39, 94–98.
[17] Abdullah, M.A., Alzate, O., Mohammad, M., McNall, R.J.,
Adang, M.J. and Dean, D.H. (2003) Introduction of Culex
toxicity into Bacillus thuringiensis Cry4Ba by protein engineering.
Appl. Environ. Microbiol. 69, 5343–5353.
[18] Gomez, I., Oltean, D., Gill, S.S., Bravo, A. and Soberon, M.
(2001) Mapping the epitope in cadherinlike receptors involved in
Bacillus thuringiensis Cry1A toxin interaction using phage display.
J. Biol. Chem. 276, 28906–28912.
[19] Kay, B.K., Kasanov, J., Knight, S. and Kurakin, A. (2000)
Convergent evolution with combinatorial peptides. FEBS Lett.
480, 55–62.
[20] Chang, C., Yu, Y.M., Dai, S.M., Law, S.K. and Gill, S.S. (1993)
High-level cryIVD and cytA gene expression in Bacillus thurin-
giensis does not require the 20-kilodalton protein, and the
coexpressed gene products are synergistic in their toxicity to
mosquitoes. Appl. Environ. Microbiol. 59, 815–821.
[21] Lereclus, D., Agaisse, H., Gominet, M. and Chaufaux, J. (1995)
Overproduction encapsulated insecticidal crystal proteins in a
Bacillus thuringiensis spoOA mutant. Bio/Technol. 13, 67–71.
[22] Thomas, W.E. and Ellar, D.J. (1983) Bacillus thuringiensis var
israelensis crystal delta-endotoxin: eﬀects on insect and mamma-
lian cells vitro and in vivo. J. Cell Sci. 60, 181–197.
[23] Nielsen-LeRoux, C. and Charles, JF. (1992) Binding of Bacillus
sphaericus binary toxin to a speciﬁc receptor on midgut brush-
border membranes from mosquito larvae. Eur J Biochem. 210,
585–590.
[24] Lereclus, D., Arantes, O., Chaufaux, J. and Lecadet, M.-M.
(1989) Transformation and expression of a cloned d-endotoxin
gene in Bacillus thuringiensis. FEMSMicrobiol. Lett. 60, 211–218.
[25] Jones, D.T., Taylor, W.R. and Thornton, J.M. (1992) A new
approach to protein fold recognition. Nature 358, 86–89.
[26] Altschul, S.F., Madden, T.L., Scha¨ﬀer, A.A., Zhang, J., Zhang,
Z., Miller, W. and Lipman, D.J. (1997) Gapped BLAST and PSI-
BLAST: a new generation of protein database search programs.
Nucleic Acids Res. 25, 3389–3402.
[27] Sali, A. and Blundell, T.L. (1993) Comparative protein modeling
by satisfaction of spatial restraints. J. Mol. Biol. 234, 779–815.
[28] Humphrey, W., Dalke, A. and Schulten, K. (1996) VMD: visual
molecular dynamics. J. Molec. Graphics 14, 33–38.
[29] Kale, L., Skeel, R., Bhandarkar, M., Brunner, R., Gursoy, A.,
Krawetz, N., Phillips, J., Shinozaki, A., Varadarajan, K. and
Schulten, K. (1999) NAMD2: greater scalability for parallel
molecular dynamics. J. Comp. Phys. 151, 283–312.
[30] Rost, B. and Sander, C. (1994) Conservation and prediction of
solvent accessibility in protein families. Proteins 20, 216–226.
[31] Rost, B. (1996) PHD: predicting one-dimensional protein struc-
ture by proﬁle-based neural networks. Methods Enzymol. 266,
525–539.
[32] Bravo, A., Go´mez, I., Conde, J., Mun˜oz-Garay, C., Sa´nchez,
J., Zhuang, M., Gill, S.S. and Sobero´n, M. (2004) Oligomer-
ization triggers binding of a Bacillus thuringienis Cry1Ab pore-
forming toxin to aminopeptidase N receptor leading to inser-
tion into membrane microdomains. Biochim. Biophys. Acta.
1667, 38–46.
